XML 24 R9.htm IDEA: XBRL DOCUMENT v3.24.1
Balance Sheet Information
12 Months Ended
Dec. 31, 2023
Disclosure Text Block Supplement [Abstract]  
Balance Sheet Information

3. BALANCE SHEET INFORMATION

Cash, cash equivalents and restricted cash

Cash, cash equivalents and restricted cash consisted of the following as of December 31 (in thousands):

 

 

 

2023

 

 

2022

 

Cash and cash equivalents

 

$

25,124

 

 

$

71,038

 

Restricted cash, non-current

 

 

2,348

 

 

 

2,767

 

Total cash, cash equivalents and restricted cash

 

$

27,472

 

 

$

73,805

 

As of December 31, 2023 and 2022, non-current restricted cash primarily consisted of security deposits on the Company’s operating leases.

Property and equipment

Property and equipment, net consisted of the following as of December 31 (in thousands):

 

 

2023

 

 

2022

 

Leasehold improvements

 

$

 

 

$

13,972

 

Software

 

 

 

 

 

4,883

 

Lab equipment

 

 

 

 

 

4,146

 

Office furniture and fixtures

 

 

869

 

 

 

1,406

 

Computer equipment

 

 

 

 

 

499

 

Construction work-in-progress

 

 

 

 

 

316

 

Total

 

 

869

 

 

 

25,222

 

Less: Accumulated depreciation

 

 

(275

)

 

 

(9,286

)

Property and equipment, net

 

$

594

 

 

$

15,936

 

Depreciation and amortization expenses were $1.5 million and $5.5 million for the years ended December 31, 2023 and 2022, respectively. For the year ended December 31, 2023, as a result of focusing solely on objectives to realize the value of the Company’s intellectual property estate, all of the Company’s property and equipment, other than certain office furniture and fixtures, was sold, donated or abandoned. The property and equipment was sold for $1.3 million, resulting in a gain of $0.6 million, which was included as a separate charge within other income, net on the Company’s consolidated statements of operations for the year ended December 31, 2023.

Accrued expenses

Accrued expenses and other current liabilities consisted of the following as of December 31 (in thousands):

 

 

 

2023

 

 

2022

 

Legal and professional fees

 

$

1,301

 

 

$

5,852

 

Research and development costs

 

 

 

 

 

1,967

 

Refundable tax credit

 

 

418

 

 

 

868

 

Restructuring costs

 

 

260

 

 

 

201

 

Accrued compensation and benefits

 

 

125

 

 

 

680

 

Accrued other

 

 

116

 

 

 

593

 

Total accrued expenses and other current liabilities

 

$

2,220

 

 

$

10,161